[1]Patent:US2007/112039,2007,A1.Locationinpatent:Page/Pagecolumn9-10
[2]Patent:CN105732490,2016,A.Locationinpatent:Paragraph0012;0030;0031;0032;0077;0083;0084
[3]Patent:WO2008/57972,2008,A1.Locationinpatent:Page/Pagecolumn34-35;43-44
[4]Patent:US2008/153876,2008,A1.Locationinpatent:Page/Pagecolumn23-24
[5]Patent:WO2008/57972,2008,A1.Locationinpatent:Page/Pagecolumn34-35
[1]Patent:CN107778223,2018,A.Locationinpatent:Paragraph0037-0038;0044-0045;0051-0052
[2]Patent:US2007/112039,2007,A1.Locationinpatent:Page/Pagecolumn8
[3]Patent:US2007/112039,2007,A1.Locationinpatent:Page/Pagecolumn8
[4]Patent:WO2008/57972,2008,A1.Locationinpatent:Page/Pagecolumn41
[5]Patent:US2008/153876,2008,A1.Locationinpatent:Page/Pagecolumn22
[6]Patent:US2007/112039,2007,A1.Locationinpatent:Page/Pagecolumn11
[7]Patent:US2008/153876,2008,A1.Locationinpatent:Page/Pagecolumn22-23
[8]Patent:WO2017/211779,2017,A1.Locationinpatent:Page/Pagecolumn23
[9]Patent:CN110372582,2019,A.Locationinpatent:Paragraph0018;0022-0023;0027-0028;0032
[1]Patent:US2007/112039,2007,A1.Locationinpatent:Page/Pagecolumn9
[2]Patent:WO2008/57972,2008,A1.Locationinpatent:Page/Pagecolumn42-43
[3]Patent:US2008/153876,2008,A1.Locationinpatent:Page/Pagecolumn23
[1]Patent:US2007/112039,2007,A1.Locationinpatent:Page/Pagecolumn11
[1]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.2179-2185
Title: The role of factor Xa inhibitors in venous thromboembolism treatment.
Journal: Vascular health and risk management 20150101
Title: Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism.
Journal: Vascular health and risk management 20150101
Title: Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa).
Journal: European heart journal 20130521
Title: A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.
Journal: Nature medicine 20130401
Title: New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function.
Journal: Drugs 20120910
Title: ACP Journal Club: review: factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement.
Journal: Annals of internal medicine 20120821
Title: The new oral anticoagulants: a challenge for hospital formularies.
Journal: Hospital practice (1995) 20120801
Title: The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review.
Journal: Expert opinion on therapeutic patents 20120601
Title: Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation.
Journal: Discovery medicine 20120601
Title: Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20120301
Title: Oral direct factor Xa inhibitors for stroke prevention in atrial fibrillation.
Journal: Nature reviews. Cardiology 20120227
Title: Stroke Prevention in Atrial Fibrillation: Where are We Now?
Journal: Clinical Medicine Insights. Cardiology 20120101
Title: Current status of new anticoagulants in the management of venous thromboembolism.
Journal: Advances in hematology 20120101
Title: Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants.
Journal: Journal of blood medicine 20120101
Title: Emerging anticoagulants.
Journal: Current medicinal chemistry 20120101
Title: Update on anti-coagulation in atrial fibrillation.
Journal: QJM : monthly journal of the Association of Physicians 20110901
Title: [Thromboembolic prophylaxis 2011: is warfarin on the wane?].
Journal: Giornale italiano di cardiologia (2006) 20110901
Title: Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery.
Journal: Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 20110301
Title: New oral anticoagulants: should they replace heparins and warfarin?
Journal: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20110101
Title: Role of factor xa inhibitors in cancer-associated thrombosis: any new data?
Journal: Advances in hematology 20110101
Title: Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.
Journal: Journal of the American College of Cardiology 20101214
Title: New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.
Journal: Clinics in chest medicine 20101201
Title: Factor Xa inhibitors: next-generation antithrombotic agents.
Journal: Journal of medicinal chemistry 20100909
Title: Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
Journal: Journal of clinical pharmacology 20100901
Title: Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation.
Journal: Current opinion in cardiology 20100701
Title: New anticoagulants for the prevention of venous thromboembolism.
Journal: Drug design, development and therapy 20100101
Title: Post-operative thromboprophylaxis: new oral thrombin and factor X inhibitors and their place in clinical practice.
Journal: F1000 medicine reports 20100101
Title: Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerations.
Journal: Journal of blood medicine 20100101
Title: Factor Xa inhibitors--new anticoagulants for secondary haemostasis.
Journal: Hamostaseologie 20090801
Title: New anticoagulants: focus on venous thromboembolism.
Journal: Current vascular pharmacology 20090701
Title: New anticoagulants for atrial fibrillation.
Journal: Seminars in thrombosis and hemostasis 20090701
Title: Rivaroxaban -- an oral, direct Factor Xa inhibitor: lessons from a broad clinical study programme.
Journal: European journal of haematology 20090501
Title: Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor.
Journal: Bioorganic & medicinal chemistry letters 20090415
Title: Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development.
Journal: Clinical pharmacokinetics 20090101
Title: A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
Journal: Thrombosis and haemostasis 20090101
Title: The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.
Journal: Vascular health and risk management 20090101
Title: Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.
Journal: Vascular health and risk management 20081201
Title: New oral anticoagulants in atrial fibrillation.
Journal: European heart journal 20080101
Title: Oral factor Xa inhibitors for venous thromboembolism prevention in major orthopedic surgery: a review.
Journal: Pathophysiology of haemostasis and thrombosis 20080101
Title: Zhang P, et al. Discovery of Betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor. Bioorg Med Chem Lett. 2009 Apr 15;19(8):21
Title: Lu G, et al. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med. 2013 Apr;19(4):446-51.
Title: Chan NC, et al. Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism. Vasc Health Risk Manag. 2015 Jun 26;11:343-51.
